Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Frequent HOXA11 and THBS2 promoter methylation, and a methylator phenotype in endometrial adenocarcinoma.

Clinical cancer research : an official journal of the American Association for Cancer Research - 1 Jun 2003

Whitcomb Bradford P, Mutch David G, Herzog Thomas J, Rader Janet S, Gibb Randall K, Goodfellow Paul J

Abstract excerpt

PURPOSE: This study was designed to determine whether there is a methylator phenotype in stage I and II endometrioid endometrial adenocarcinoma, and if so, whether methylation correlates with recurrence. EXPERIMENTAL DESIGN: Bisulfite-converted DNAs from 24 stage I and II primary cancers (12 recu...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Adenocarcinoma
Share to beta Catenin
Share to Cytoskeletal Proteins

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Endometrial Neoplasms

Share to Genes, p16

Share to Homeodomain Proteins

Share to Thrombospondin 1

Share to Thrombospondins

Source

Identifiers

PMID: 12796396

Genes

HOXA11
THBS2
CTNNB1
MLH1
THBS1
VDR

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 1 Sept 2026. Prepared record publication-12796396-2026-09-01.1. Manifest publication-graph-cohort-2026-09-01.1.

Source receipt: PubMed via Helena Literature Corpus, retrieved 1 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Frequent HOXA11 and THBS2 promoter methylation, and a methylator phenotype in endometrial adenocarcinoma.PMID 12796396Read ↗

Identification of endometrial cancer methylation features using combined methylation analysis methods.Semantic proximity Read ↗

Differential Methylation Hybridization Array of Endometrial Cancers Reveals Two Novel Cancer-Specific Methylation MarkersSemantic proximity Read ↗

Status and significance of CpG island methylator phenotype in endometrial cancer.Semantic proximity Read ↗

[Prognostic stratification value of MLH1 promoter methylation in endometrioid endometrial carcinomas with a dMMR molecular phenotype].Semantic proximity Read ↗

The Prognostic Impact of MLH1 Promoter Hypermethylation in Stage I-II Endometrial Cancer Treated With Adjuvant Radiation Therapy: A Multi-Institutional Retrospective Study.Semantic proximity Read ↗

Genome-wide DNA methylation profile of early-onset endometrial cancer: its correlation with genetic aberrations and comparison with late-onset endometrial cancerSemantic proximity Read ↗

Interplay between promoter methylation and chromosomal loss in gene silencing at 3p11-p14 in cervical cancerSemantic proximity Read ↗

DNMT3b overexpression contributes to a hypermethylator phenotype in human breast cancer cell lines.Semantic proximity Read ↗

Defective mismatch repair and the development of recurrent endometrial carcinoma.Semantic proximity Read ↗

Accumulation of Promoter Methylation Suggests Epigenetic Progression in Squamous Cell Carcinoma of the EsophagusSemantic proximity Read ↗

DNA hypermethylation in breast cancer and its association with clinicopathological features.Semantic proximity Read ↗

CpG island methylator phenotype associated with tumor recurrence in tumor-node-metastasis stage I hepatocellular carcinoma.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.